SRX Global Inc. quarterly report, Q3 FY2017

Business context and reporting period

Sport Endurance, Inc. filed this Form 10-Q for the fiscal third quarter and nine months ended May 31, 2017; its fiscal year ends August 31. The company develops, markets, and distributes dietary supplements. The request identifies SRX Global Inc., while the filing names Sport Endurance, Inc.; verify the issuer identity and ticker.

Financial results and liquidity

Gross profit was approximately 80.7% of revenue for the quarter and 77.7% for the nine-month period. Revenue remained minimal; the filing provides no meaningful operating scale from which to assess sustainable margins.

For the nine months, cash used in operating activities was $87,713; financing provided $79,000, and cash declined by $8,713 to $1,484. At May 31, current assets were $16,469 and current liabilities $1,143,120, producing a working-capital deficit of $1,126,651. Total liabilities included a $284,547 derivative liability, $204,893 of related-party notes and accrued interest, and convertible notes carried at $442,706 net of discounts. The filing separately reports $614,258 aggregate principal for the restructured January–February 2017 convertible notes. Stockholders’ deficit was $1,126,651. No cash interest or income taxes were paid during the nine months.

Material changes versus prior comparable period

• Quarterly net loss was broadly flat year over year: $465,671 versus $464,483. Nine-month net loss increased to $1,421,384 from $490,655.
• Nine-month G&A rose to $341,827 from $74,993, which management attributed primarily to implementing its business plan. Professional fees rose to $79,332 from $63,217.
• Interest expense increased to $658,758 from $182,555, primarily from amortization of convertible-debt discounts. The $342,270 nine-month derivative revaluation loss was noncash and substantially exceeded the prior-year $1,001 loss.
• Current liabilities increased from $590,963 at August 31, 2016 to $1,143,120 at May 31, 2017; cash fell from $10,197 to $1,484.

Outlook, risks, and unusual items

• Management expects revenue, G&A, and professional fees to increase as it implements its business plan, but anticipates operating losses over the next 12 months and does not expect revenue to meet working-capital needs. No quantified revenue or earnings guidance is provided.
• The filing states that recurring losses, a $2,786,598 accumulated deficit, a $1,126,651 working-capital deficit, and inadequate cash raise substantial doubt about the company’s ability to continue as a going concern. Continued operations depend on obtaining debt or equity financing; management says it cannot assure success.
• Convertible debt was repeatedly extended through forbearance agreements and incurred penalties and added principal. Subsequent events disclosed extensions of the relevant notes to December 27, 2017, in exchange for principal increases; holders waived a stated $163,151 default penalty. The company also reported additional CEO loans of $18,000 in June and a further $25,000 principal conversion into shares.
• The CEO had $96,000 of accrued salary at May 31 and loaned the company $204,000 during the nine months. The company reported ineffective disclosure controls, citing no independent board or audit committee, limited segregation of duties, and reliance on a financial consultant for financial reporting.
• Management identified no material pending or threatened litigation and no material off-balance-sheet arrangements. The filing reports no specific market-risk disclosure because the company is a smaller reporting company.

Important facts for investors to verify

• Confirm the issuer’s identity and ticker, given the mismatch between the request metadata and the filing’s registrant name.
• Verify current cash, financing availability, and whether the company can meet operating needs and debt obligations through the extended maturities.
• Review the convertible-note balances, default/forbearance terms, variable conversion-price provisions, and potential dilution.
• Assess whether product sales can grow meaningfully and whether inventory and the business plan can generate cash; reported nine-month revenue was only $1,034.
• Review the assumptions underlying the Level 3 derivative liability valuation and the company’s plans to remediate ineffective disclosure controls.